Skip to content
  • Home
  • About
  • News
    • Top
    • Recent News
    • Archive
  • Account
    • Profile
    • Manage Corporate Account
    • Orders
    • Billing
    • Cancel
  • Subscription Plans
  • Contact
  • Login
  • Home
  • About
  • News
    • Top
    • Recent News
    • Archive
  • Account
    • Profile
    • Manage Corporate Account
    • Orders
    • Billing
    • Cancel
  • Subscription Plans
  • Contact
  • Login

TB Epidemic Challenges and Local Manufacturing Needs

Understand the impact of stockouts on the South Africa TB epidemic and SANAC's strategies for effective solutions.

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

TB Deaths in South Africa Persist Despite Drop in Infections

Discover the paradox of TB deaths in South Africa as new infections decline but mortality remains high. Learn more here.

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

HIV deaths in SA may be four times higher than reported

The latest SAMRC study uncovers severe underreporting of HIV deaths in SA, revealing gaps that demand urgent public health attention.

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

Casual contact drives TB spread more than household exposure

Insights from a KZN study reveal that casual contact drives TB, shifting the focus from close household exposure to community interactions.

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

Research faces funding crisis after NIH grant cuts

South African researchers face significant funding cuts from the US National Institutes of Health (NIH), jeopardising critical HIV/AIDS and TB research.

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

Competition Commission and J&J reach TB drug agreement

Following an agreement with the Competition Commission, J&J will not enforce its TB drug patent in 134 countries and will reduce the drug price in South Africa.

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here